ZIVOZivo Bioscience, Inc.同业对比
Zivo Bioscience, Inc. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZIVO本股 | $5M#8 | — | — | 31.3x#3 | 468.6%#1 | -72.1%#11 | -8498.9%#2 | — | — | — | 0.0%#2 | — |
| ENGNW | $12M#2 | 0.1x#3 | 0.1x#2 | — | — | -112.7%#12 | — | -50.9%#2 | — | — | -77.0%#8 | — |
| PLUR | $14M#1 | — | — | 13.4x#1 | -24.0%#2 | -5.5%#6 | -2454.5%#1 | — | — | — | -76.2%#7 | — |
| INAB | $11M#3 | — | 0.6x#4 | — | — | 36.1%#3 | — | -105.9%#5 | — | — | -48.1%#4 | — |
| SNTI | $10M#4 | — | — | 449.8x#6 | — | -16.4%#9 | -312631.8%#8 | — | — | — | — | — |
| CERO | $7M#5 | — | — | — | — | — | — | — | — | — | -98.2%#11 | 1.8%#3 |
| AIM | $6M#6 | — | 0.8x#6 | 71.7x#5 | -48.2%#4 | 19.4%#4 | -13254.5%#4 | -180.2%#6 | -7934.7%#5 | — | -91.8%#9 | — |
| CELZ | $6M#7 | — | 0.7x#5 | 996.5x#7 | -45.5%#3 | -9.1%#7 | -102380.2%#7 | -69.3%#3 | -66.1%#2 | 3#1 | -73.8%#5 | — |
| PMCB | $4M#9 | — | 0.2x#3 | — | — | -163.4%#13 | — | -70.6%#4 | -56.0%#1 | — | — | — |
| BKHAR | $4M#10 | — | — | — | — | -30.6%#10 | — | — | — | — | — | 1204.0%#1 |
| LIMNW | $4M#11 | — | 12.5x#8 | — | — | -187.8%#14 | — | -3395.2%#8 | -170.3%#3 | — | — | — |
| CLDI | $3M#13 | 0.0x#1 | 1.0x#7 | 70.6x#4 | — | 10.1%#5 | -44977.8%#6 | -635.4%#7 | — | — | -95.1%#10 | — |
| BCAB | — | 0.1x#2 | — | — | — | -14.6%#8 | -19768.3%#5 | — | — | — | — | — |
| WINT | $3M#12 | — | — | 17.1x#2 | -88.9%#5 | 91.2%#2 | -13201.5%#3 | — | -308.7%#4 | — | -75.1%#6 | 19.4%#2 |
| ESLAW | $3M#14 | — | — | — | — | — | — | — | — | — | 5.4%#1 | — |
| SABSW | $3M#15 | 0.1x#4 | 0.0x#1 | — | -100.0%#6 | 138.9%#1 | — | 6.2%#1 | — | — | -24.9%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-19。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议